{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:37:39Z","timestamp":1791265059788,"version":"4.1.0"},"reference-count":70,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4S","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Plast Surg"],"published-print":{"date-parts":[[2019,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Development of diabetic foot ulcers is a common complication of diabetes. Standard-of-care (SOC) therapy alone is often not sufficient to heal these wounds, resulting in application of adjuvant wound therapies including biologic skin substitutes. Although a variety of products exist, it has been difficult to formulate conclusions on their clinical efficacy. We therefore performed a systematic review and meta-analysis on the efficacy of healing diabetic foot ulcers with biologic skin substitutes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic review was conducted in accordance with PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses). Four electronic databases (PubMed\/MEDLINE, EMBASE [Ovid], Cochrane CENTRAL [Ovid], and Web of Science) were searched from inception through February 27, 2019. Searches included keywords and subject headings pertaining to 3 main concepts: biologic skin substitutes, wound healing, and diabetic foot ulcers. Cochrane randomized controlled trial filters were used to narrow results. Data were extracted from 54 included articles, and risk-of-bias assessments were conducted by 2 independent reviewers. The primary objective was to calculate a pooled risk ratio for the proportion of wounds completely closed by 12 weeks. Secondary objectives included a pooled risk ratio for the proportion of wounds completely closed by 6 weeks and mean time to healing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Twenty-five studies were identified that assessed the proportion of complete wound closure by 12 weeks. We found that wounds treated with biologic dressings were 1.67 times more likely to heal by 12 weeks than those treated with SOC dressings (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.00001). Five studies assessed the proportion of complete wound closure by 6 weeks. Wounds treated with biologic dressings were 2.81 times more likely to heal by 6 weeks than those treated with SOC dressings (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.0001). Descriptively, 29 of 31 studies that assessed time to healing favored biologic dressings over SOC dressings.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This systematic review provides supporting evidence that biologic skin substitutes are more effective than SOC dressings at healing diabetic foot ulcers by 12 weeks. Future studies must address the relative benefits of different skin substitutes as well as the long-term implications of these products and their financial considerations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/sap.0000000000002096","type":"journal-article","created":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T06:10:49Z","timestamp":1568182249000},"page":"S31-S44","source":"Crossref","is-referenced-by-count":31,"title":["Evidence for Healing Diabetic Foot Ulcers With Biologic Skin Substitutes"],"prefix":"10.1097","volume":"83","author":[{"given":"Alex J.","family":"Gordon","sequence":"first","affiliation":[{"name":"Hansj\u00f6rg Wyss Department of Plastic Surgery, New York University Langone Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allyson R.","family":"Alfonso","sequence":"additional","affiliation":[{"name":"Hansj\u00f6rg Wyss Department of Plastic Surgery, New York University Langone Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joey","family":"Nicholson","sequence":"additional","affiliation":[{"name":"New York University Health Sciences Library, New York University School of Medicine, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest S.","family":"Chiu","sequence":"additional","affiliation":[{"name":"Hansj\u00f6rg Wyss Department of Plastic Surgery, New York University Langone Health"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"bib1-20230925","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.diabres.2017.03.024","article-title":"IDF Diabetes Atlas: global estimates for the prevalence of diabetes for 2015 and 2040","volume":"128","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"key":"bib2-20230925","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1056\/NEJMra1615439","article-title":"Diabetic foot ulcers and their recurrence","volume":"376","year":"2017","journal-title":"N Engl J Med"},{"key":"bib3-20230925","doi-asserted-by":"crossref","first-page":"692","DOI":"10.2337\/diacare.22.5.692","article-title":"Healing of diabetic neuropathic foot ulcers receiving standard treatment. A meta-analysis","volume":"22","year":"1999","journal-title":"Diabetes Care"},{"key":"bib4-20230925","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1464-5491.2004.01375.x","article-title":"Healing diabetic neuropathic foot ulcers: are we getting better?","volume":"22","year":"2005","journal-title":"Diabet Med"},{"key":"bib5-20230925","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.2337\/diacare.26.6.1879","article-title":"Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial","volume":"26","year":"2003","journal-title":"Diabetes Care"},{"issue":"suppl 2","key":"bib6-20230925","first-page":"3s","article-title":"The management of diabetic foot: a clinical practice guideline by the Society for Vascular Surgery in collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine","volume":"63","year":"2016","journal-title":"J Vasc Surg"},{"issue":"suppl","key":"bib7-20230925","first-page":"S23","article-title":"Biologic and synthetic skin substitutes: an overview","volume":"43","year":"2010","journal-title":"Indian J Plast Surg"},{"key":"bib8-20230925","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1089\/ten.teb.2017.0477","article-title":"A universal classification system of skin substitutes inspired by factorial design","volume":"24","year":"2018","journal-title":"Tissue Eng Part B Rev"},{"key":"bib9-20230925","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.burns.2007.04.016","article-title":"Classification of skin substitutes","volume":"34","year":"2008","journal-title":"Burns"},{"key":"bib10-20230925","first-page":"696","article-title":"Skin substitutes: current concepts and a new classification system","volume":"26","year":"2011","journal-title":"Rev Bras Cir Plast"},{"key":"bib11-20230925","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1600-0625.2010.01087.x","article-title":"Regenerative medicine in dermatology: biomaterials, tissue engineering, stem cells, gene transfer and beyond","volume":"19","year":"2010","journal-title":"Exp Dermatol"},{"key":"bib12-20230925","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0305-4179(01)00018-3","article-title":"Skin substitutes: a review","volume":"27","year":"2001","journal-title":"Burns"},{"key":"bib13-20230925","first-page":"Cd011255","article-title":"Skin grafting and tissue replacement for treating foot ulcers in people with diabetes","volume":"2","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"bib14-20230925","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement","volume":"8","year":"2010","journal-title":"Int J Surg"},{"key":"bib18-20230925","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/PRS.0b013e3181dc54ee","article-title":"How to practice evidence-based medicine","volume":"126","year":"2010","journal-title":"Plast Reconstr Surg"},{"key":"bib20-20230925","first-page":"i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","year":"2016","journal-title":"BMJ"},{"issue":"suppl 1","key":"bib21-20230925","first-page":"S145","article-title":"Effective management of major lower extremity wounds using an acellular regenerative tissue matrix: a pilot study","volume":"27","year":"2004","journal-title":"Orthopedics"},{"key":"bib22-20230925","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1742-481X.2006.00209.x","article-title":"The use of an acellular dermal regenerative tissue matrix in the treatment of lower extremity wounds: a prospective 16-week pilot study","volume":"3","year":"2006","journal-title":"Int Wound J"},{"key":"bib23-20230925","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s13304-017-0461-9","article-title":"To evaluate the efficacy of an acellular flowable matrix in comparison with a wet dressing for the treatment of patients with diabetic foot ulcers: a randomized clinical trial","volume":"69","year":"2017","journal-title":"Updates Surg"},{"key":"bib24-20230925","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.2337\/diacare.26.10.2853","article-title":"HYAFF 11-based autologous dermal and epidermal grafts in the treatment of noninfected diabetic plantar and dorsal foot ulcers: a prospective, multicenter, controlled, randomized clinical trial","volume":"26","year":"2003","journal-title":"Diabetes Care"},{"key":"bib25-20230925","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1089\/wound.2015.0645","article-title":"The management of diabetic foot ulcers with porcine small intestine submucosa tri-layer matrix: a randomized controlled trial","volume":"4","year":"2015","journal-title":"Adv Wound Care (New Rochelle)"},{"key":"bib26-20230925","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/iwj.12954","article-title":"Use of an aseptically processed, dehydrated human amnion and chorion membrane improves likelihood and rate of healing in chronic diabetic foot ulcers: a prospective, randomised, multi-centre clinical trial in 80 patients","volume":"15","year":"2018","journal-title":"Int Wound J"},{"key":"bib27-20230925","doi-asserted-by":"crossref","first-page":"e1095","DOI":"10.1097\/GOX.0000000000001095","article-title":"Aseptically processed placental membrane improves healing of diabetic foot ulcerations: prospective, randomized clinical trial","volume":"4","year":"2016","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"bib28-20230925","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/wrr.12357","article-title":"A clinical trial of Integra Template for diabetic foot ulcer treatment","volume":"23","year":"2015","journal-title":"Wound Repair Regen"},{"key":"bib29-20230925","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/1534734609331597","article-title":"Apligraf in the treatment of neuropathic diabetic foot ulcers","volume":"8","year":"2009","journal-title":"Int J Low Extrem Wounds"},{"key":"bib30-20230925","doi-asserted-by":"crossref","first-page":"350","DOI":"10.2337\/diacare.19.4.350","article-title":"Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers","volume":"19","year":"1996","journal-title":"Diabetes Care"},{"key":"bib31-20230925","first-page":"77","article-title":"Improved healing of diabetic foot ulcers after grafting with a living human dermal replacement","volume":"11","year":"1999","journal-title":"Wounds"},{"key":"bib32-20230925","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/wrr.12020","article-title":"Randomized controlled trial on collagen\/oxidized regenerated cellulose\/silver treatment","volume":"21","year":"2013","journal-title":"Wound Repair Regen"},{"key":"bib33-20230925","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1524-475X.2010.00593.x","article-title":"The treatment of diabetic foot ulcers with uncultured, processed lipoaspirate cells: a pilot study","volume":"18","year":"2010","journal-title":"Wound Repair Regen"},{"key":"bib34-20230925","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1067-2516(02)80047-3","article-title":"Healing of chronic foot ulcers in diabetic patients treated with a human fibroblast-derived dermis","volume":"41","year":"2002","journal-title":"J Foot Ankle Surg"},{"key":"bib35-20230925","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.jamcollsurg.2016.02.023","article-title":"Composite skin grafting with human acellular dermal matrix scaffold for treatment of diabetic foot ulcers: a randomized controlled trial","volume":"222","year":"2016","journal-title":"J Am Coll Surg"},{"key":"bib36-20230925","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jdiacomp.2007.03.006","article-title":"Synergistic action of protease-modulating matrix and autologous growth factors in healing of diabetic foot ulcers. A prospective randomized trial","volume":"21","year":"2007","journal-title":"J Diabetes Complications"},{"key":"bib37-20230925","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/iwj.12329","article-title":"The efficacy and safety of Grafix(\u00ae) for the treatment of chronic diabetic foot ulcers: results of a multi-centre, controlled, randomised, blinded, clinical trial","volume":"11","year":"2014","journal-title":"Int Wound J"},{"key":"bib38-20230925","first-page":"275","article-title":"Open-label extension phase of a chronic diabetic foot ulcer multicenter, controlled, randomized clinical trial using cryopreserved placental membrane","volume":"30","year":"2018","journal-title":"Wounds"},{"key":"bib39-20230925","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/wrr.12428","article-title":"Hyaluronic acid dressing (Healoderm) in the treatment of diabetic foot ulcer: a prospective, randomized, placebo-controlled, single-center study","volume":"24","year":"2016","journal-title":"Wound Repair Regen"},{"key":"bib40-20230925","first-page":"230","article-title":"Effectiveness of bilayered cellular matrix in healing of neuropathic diabetic foot ulcers: results of a multicenter pilot trial","volume":"15","year":"2003","journal-title":"Wounds"},{"key":"bib41-20230925","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.2337\/diacare.26.6.1701","article-title":"The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial","volume":"26","year":"2003","journal-title":"Diabetes Care"},{"key":"bib42-20230925","first-page":"248","article-title":"Comparison of a bioimplant dressing with a wet dressing for the treatment of diabetic foot ulcers: a randomized, controlled clinical trial","volume":"28","year":"2016","journal-title":"Wounds"},{"key":"bib43-20230925","first-page":"286","article-title":"Expression of matrix-metalloproteases in the fluid of chronic diabetic foot wounds treated with a protease absorbent dressing","volume":"119","year":"2011","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"bib44-20230925","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2217\/17460751.2.6.887","article-title":"Randomized, controlled, single-blind study on use of autologous keratinocytes on a transfer dressing to treat nonhealing diabetic ulcers","volume":"2","year":"2007","journal-title":"Regen Med"},{"key":"bib45-20230925","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/j.1525-1594.1997.tb00476.x","article-title":"A metabolically active human dermal replacement for the treatment of diabetic foot ulcers","volume":"21","year":"1997","journal-title":"Artif Organs"},{"key":"bib46-20230925","first-page":"79","article-title":"Evaluation of a human skin equivalent for the treatment of diabetic foot ulcers in a prospective, randomized, clinical trial","volume":"11","year":"1999","journal-title":"Wounds"},{"key":"bib47-20230925","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1742-481X.2009.00585.x","article-title":"Clinical effectiveness of an acellular dermal regenerative tissue matrix compared to standard wound management in healing diabetic foot ulcers: a prospective, randomised, multicentre study","volume":"6","year":"2009","journal-title":"Int Wound J"},{"key":"bib48-20230925","first-page":"698","article-title":"Graftskin treatment of difficult to heal diabetic foot ulcers: one center's experience","volume":"28","year":"2002","journal-title":"Dermatol Surg"},{"key":"bib49-20230925","doi-asserted-by":"crossref","first-page":"73","DOI":"10.7547\/1000073","article-title":"Confirmatory data from EU study supports Apligraf for the treatment of neuropathic diabetic foot ulcers","volume":"100","year":"2010","journal-title":"J Am Podiatr Med Assoc"},{"key":"bib50-20230925","first-page":"70","article-title":"A prospective, randomized, multicenter, controlled evaluation of the use of dehydrated amniotic membrane allograft compared to standard of care for the closure of chronic diabetic foot ulcer","volume":"28","year":"2016","journal-title":"Wounds"},{"key":"bib51-20230925","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/iwj.12976","article-title":"A confirmatory study on the efficacy of dehydrated human amnion\/chorion membrane dHACM allograft in the management of diabetic foot ulcers: a prospective, multicentre, randomised, controlled study of 110 patients from 14 wound clinics","volume":"16","year":"2019","journal-title":"Int Wound J"},{"key":"bib52-20230925","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/iwj.13001","article-title":"A multicentre prospective randomised controlled comparative parallel study of dehydrated human umbilical cord (EpiCord) allograft for the treatment of diabetic foot ulcers","volume":"16","year":"2019","journal-title":"Int Wound J"},{"key":"bib53-20230925","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1177\/1534734611409371","article-title":"Two-step autologous grafting using HYAFF scaffolds in treating difficult diabetic foot ulcers: results of a multicenter, randomized controlled clinical trial with long-term follow-up","volume":"10","year":"2011","journal-title":"Int J Low Extrem Wounds"},{"key":"bib54-20230925","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/WON.0b013e31822ad290","article-title":"Effect of oxidized regenerated cellulose\/collagen matrix on proteases in wound exudate of patients with diabetic foot ulcers","volume":"38","year":"2011","journal-title":"J Wound Ostomy Continence Nurs"},{"key":"bib55-20230925","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2337\/diacare.24.2.290","article-title":"Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial","volume":"24","year":"2001","journal-title":"Diabetes Care"},{"key":"bib56-20230925","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1001\/archsurg.137.7.822","article-title":"A randomized, controlled trial of promogran (a collagen\/oxidized regenerated cellulose dressing) vs standard treatment in the management of diabetic foot ulcers","volume":"137","year":"2002","journal-title":"Arch Surg"},{"key":"bib57-20230925","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1524-475X.2012.00809.x","article-title":"Treatment of diabetic foot ulcers using cultured allogeneic keratinocytes\u2014a pilot study","volume":"20","year":"2012","journal-title":"Wound Repair Regen"},{"key":"bib58-20230925","doi-asserted-by":"crossref","first-page":"521","DOI":"10.12968\/jowc.2014.23.11.521","article-title":"Randomised controlled clinical trial for autologous fibroblast\u2013hyaluronic acid complex in treating diabetic foot ulcers","volume":"23","year":"2014","journal-title":"J Wound Care"},{"key":"bib59-20230925","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/iwj.12097","article-title":"A prospective randomised comparative parallel study of amniotic membrane wound graft in the management of diabetic foot ulcers","volume":"10","year":"2013","journal-title":"Int Wound J"},{"key":"bib60-20230925","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/iwj.12920","article-title":"An aseptically processed, acellular, reticular, allogenic human dermis improves healing in diabetic foot ulcers: a prospective, randomised, controlled, multicentre follow-up trial","volume":"15","year":"2018","journal-title":"Int Wound J"},{"key":"bib61-20230925","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/iwj.12600","article-title":"A prospective, randomised, controlled, multicentre clinical trial examining healing rates, safety and cost to closure of an acellular reticular allogenic human dermis versus standard of care in the treatment of chronic diabetic foot ulcers","volume":"14","year":"2017","journal-title":"Int Wound J"},{"key":"bib62-20230925","first-page":"897","article-title":"Wound bed preparation for ischemic diabetic foot ulcer","volume":"8","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"bib63-20230925","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/wrr.12645","article-title":"A multicenter, randomized, single-blind trial comparing the efficacy of viable cryopreserved placental membrane to human fibroblast-derived dermal substitute for the treatment of chronic diabetic foot ulcers","volume":"26","year":"2018","journal-title":"Wound Repair Regen"},{"key":"bib64-20230925","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1524-475X.2011.00669.x","article-title":"Formulated collagen gel accelerates healing rate immediately after application in patients with diabetic neuropathic foot ulcers","volume":"19","year":"2011","journal-title":"Wound Repair Regen"},{"key":"bib65-20230925","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/wrr.12551","article-title":"A randomized clinical trial of a human acellular dermal matrix demonstrated superior healing rates for chronic diabetic foot ulcers over conventional care and an active acellular dermal matrix comparator","volume":"25","year":"2017","journal-title":"Wound Repair Regen"},{"key":"bib66-20230925","first-page":"e10","article-title":"Healing rates in a multicenter assessment of a sterile, room temperature, acellular dermal matrix versus conventional care wound management and an active comparator in the treatment of full-thickness diabetic foot ulcers","volume":"16","year":"2016","journal-title":"Eplasty"},{"key":"bib67-20230925","first-page":"184","article-title":"A prospective comparison of diabetic foot ulcers treated with either a cryopreserved skin allograft or a bioengineered skin substitute","volume":"23","year":"2011","journal-title":"Wounds"},{"issue":"suppl 7","key":"bib68-20230925","first-page":"S18","article-title":"Evaluation of tissue engineering products for the management of neuropathic diabetic foot ulcers: an interim analysis","volume":"25","year":"2016","journal-title":"J Wound Care"},{"key":"bib69-20230925","first-page":"111","article-title":"Living cells or collagen matrix: which is more beneficial in the treatment of diabetic foot ulcers?","volume":"20","year":"2008","journal-title":"Wounds"},{"issue":"5 pt 1","key":"bib70-20230925","first-page":"258","article-title":"Randomized clinical trial comparing OASIS Wound Matrix to Regranex Gel for diabetic ulcers","volume":"18","year":"2005","journal-title":"Adv Skin Wound Care"},{"key":"bib71-20230925","first-page":"26","article-title":"A prospective, multicenter, randomized, controlled clinical trial comparing a bioengineered skin substitute to a human skin allograft","volume":"60","year":"2014","journal-title":"Ostomy Wound Manage"},{"key":"bib72-20230925","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/iwj.12242","article-title":"A prospective, randomised comparative study of weekly versus biweekly application of dehydrated human amnion\/chorion membrane allograft in the management of diabetic foot ulcers","volume":"11","year":"2014","journal-title":"Int Wound J"},{"key":"bib73-20230925","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/iwj.12395","article-title":"A prospective, randomised, controlled, multi-centre comparative effectiveness study of healing using dehydrated human amnion\/chorion membrane allograft, bioengineered skin substitute or standard of care for treatment of chronic lower extremity diabetic ulcers","volume":"12","year":"2015","journal-title":"Int Wound J"},{"key":"bib74-20230925","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/iwj.12566","article-title":"Treatment of chronic diabetic lower extremity ulcers with advanced therapies: a prospective, randomised, controlled, multi-centre comparative study examining clinical efficacy and cost","volume":"13","year":"2016","journal-title":"Int Wound J"}],"container-title":["Annals of Plastic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/SAP.0000000000002096","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T03:07:06Z","timestamp":1721704026000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/SAP.0000000000002096"}},"subtitle":["A Systematic Review and Meta-Analysis"],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":70,"journal-issue":{"issue":"4S","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/sap.0000000000002096","relation":{},"ISSN":["1536-3708","0148-7043"],"issn-type":[{"value":"1536-3708","type":"electronic"},{"value":"0148-7043","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]}}}